{"id":"mal-application","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL49789","moleculeType":"Small molecule","molecularWeight":"570.55"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"MAL application is a protein that plays a crucial role in various cellular processes. By modulating its activity, MAL application can affect various cellular functions.","oneSentence":"MAL application works by modulating the activity of the MAL protein.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:53:50.264Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Various conditions"}]},"trialDetails":[{"nctId":"NCT07381972","phase":"PHASE3","title":"Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-11-24","conditions":"Nodular Basal Cell Carcinoma of Skin","enrollment":142},{"nctId":"NCT07304414","phase":"NA","title":"Optokinetic Stimulation in Mal de Debarquement Syndrome: Case Report","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2025-10-24","conditions":"Mal de Debarquement Syndrome (MdDS)","enrollment":1},{"nctId":"NCT07290959","phase":"NA","title":"Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK","status":"COMPLETED","sponsor":"San Salvatore Hospital of L'Aquila","startDate":"2025-01-02","conditions":"Actinic Keratosis (AK)","enrollment":55},{"nctId":"NCT06975774","phase":"PHASE1","title":"Phase II Clinical Clical of the Pure Protein Derivatives of BCG","status":"COMPLETED","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2023-07-26","conditions":"Tuberculosis","enrollment":30},{"nctId":"NCT03909646","phase":"PHASE4","title":"Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2019-05-27","conditions":"Bowen's Disease","enrollment":250},{"nctId":"NCT06507644","phase":"NA","title":"Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment","status":"NOT_YET_RECRUITING","sponsor":"University of Nove de Julho","startDate":"2024-11-30","conditions":"Actinic Keratoses","enrollment":144},{"nctId":"NCT05522036","phase":"NA","title":"Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®","status":"COMPLETED","sponsor":"Centre Dermatologique du Roy","startDate":"2022-01-01","conditions":"Actinic Keratoses","enrollment":25},{"nctId":"NCT04130711","phase":"NA","title":"HAptic Neurofeedback Design for Stroke","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2019-10-23","conditions":"Stroke","enrollment":76},{"nctId":"NCT00843323","phase":"NA","title":"Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2008-12","conditions":"Actinic Keratosis, Photoaging, Solar Elastosis","enrollment":26},{"nctId":"NCT04085367","phase":"PHASE3","title":"Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2019-09-30","conditions":"Actinic Keratoses","enrollment":557},{"nctId":"NCT00535080","phase":"","title":"Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease","status":"NO_LONGER_AVAILABLE","sponsor":"Galderma R&D","startDate":"","conditions":"Field Actinic Keratoses, Basal Cell Carcinoma, Bowen's Disease","enrollment":""},{"nctId":"NCT03963765","phase":"NA","title":"Transepidermal Application of Metilaminolevulinate in Daylight PDT in the Treatment of Photodamaged Skin","status":"COMPLETED","sponsor":"Universidade Federal Fluminense","startDate":"2017-02-03","conditions":"Skin Diseases","enrollment":40},{"nctId":"NCT02736760","phase":"PHASE4","title":"Daylight-PDT With MAL for AK and Photodamaged Skin","status":"COMPLETED","sponsor":"University Hospital Regensburg","startDate":"2016-03-03","conditions":"Actinic Keratoses, Photodamaged Skin","enrollment":58},{"nctId":"NCT02878382","phase":"NA","title":"Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2016-10","conditions":"Actinic Keratosis","enrollment":20},{"nctId":"NCT02464709","phase":"PHASE4","title":"Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2015-06","conditions":"Actinic Keratosis, Natural Daylight Photodynamic Therapy","enrollment":72},{"nctId":"NCT02354391","phase":"PHASE2","title":"Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis","status":"UNKNOWN","sponsor":"Pacific Dermaesthetics","startDate":"2015-01","conditions":"Actinic Keratosis","enrollment":20},{"nctId":"NCT03731988","phase":"PHASE4","title":"Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2017-02-01","conditions":"Actinic Keratosis","enrollment":47},{"nctId":"NCT03076918","phase":"NA","title":"Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2014-09","conditions":"Keratosis, Actinic","enrollment":29},{"nctId":"NCT03012009","phase":"NA","title":"Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-09","conditions":"Bowen's Disease, Superficial Basal Cell Carcinoma","enrollment":16},{"nctId":"NCT03325803","phase":"PHASE1","title":"Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2015-09-01","conditions":"Actinic Dermatosis","enrollment":45},{"nctId":"NCT03320447","phase":"PHASE1","title":"Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2011-10-30","conditions":"Bowen's Disease","enrollment":60},{"nctId":"NCT02799069","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2008-04","conditions":"Actinic Keratosis","enrollment":571},{"nctId":"NCT01449786","phase":"PHASE2","title":"Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2012-03-14","conditions":"Birch Pollen Related Apple Allergy, Birch Pollen Allergy","enrollment":60},{"nctId":"NCT02976727","phase":"PHASE1","title":"Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2014-05","conditions":"Actinic Dermatosis","enrollment":48},{"nctId":"NCT01893203","phase":"PHASE4","title":"Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2013-08","conditions":"Multiple Actinic Keratoses","enrollment":14},{"nctId":"NCT02670655","phase":"PHASE1","title":"Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2014-06","conditions":"Actinic Keratosis","enrollment":45},{"nctId":"NCT02666534","phase":"PHASE1","title":"Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-01","conditions":"Microinvasive Squamous Cell Carcinoma","enrollment":45},{"nctId":"NCT02647151","phase":"PHASE4","title":"Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel","status":"UNKNOWN","sponsor":"Fundación Instituto Valenciano de Oncología","startDate":"2015-12","conditions":"Actinic Keratosis","enrollment":50},{"nctId":"NCT02357771","phase":"PHASE3","title":"Probiotic Lozenge Reduce Streptococcus Mutans in Plaque in Orthodontic Bracket Patients","status":"COMPLETED","sponsor":"Next Gen Pharma India Pvt. Ltd.","startDate":"2015-04","conditions":"Malocclusion","enrollment":30},{"nctId":"NCT02511145","phase":"PHASE1","title":"Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-02","conditions":"Healthy","enrollment":10},{"nctId":"NCT02139618","phase":"PHASE2","title":"Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage","status":"COMPLETED","sponsor":"Fundación Dermabase","startDate":"2014-04","conditions":"Facial Photodamage","enrollment":60},{"nctId":"NCT02372370","phase":"PHASE1","title":"Pretreatments of the Skin Prior to PDT","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2014-12","conditions":"Healthy","enrollment":12},{"nctId":"NCT01292668","phase":"PHASE1","title":"Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2011-03","conditions":"Basal Cell Carcinoma of the Skin, Pain, Recurrent Skin Cancer","enrollment":21},{"nctId":"NCT02248298","phase":"PHASE1","title":"Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-01","conditions":"Actinic Keratosis","enrollment":93},{"nctId":"NCT02198469","phase":"PHASE1","title":"Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-01","conditions":"Actinic Cheilitis","enrollment":33},{"nctId":"NCT02018679","phase":"PHASE1","title":"Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2011-03","conditions":"Nodular Basal Cell Carcinoma","enrollment":34},{"nctId":"NCT00933543","phase":"PHASE2","title":"Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Photocure","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":107},{"nctId":"NCT00594425","phase":"PHASE2","title":"Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne","status":"COMPLETED","sponsor":"Photocure","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":150},{"nctId":"NCT01912976","phase":"PHASE1","title":"Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2011-03","conditions":"Bowen's Disease","enrollment":21},{"nctId":"NCT00673933","phase":"PHASE2","title":"Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris","status":"COMPLETED","sponsor":"Photocure","startDate":"2008-05","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00926952","phase":"PHASE3","title":"Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion","status":"COMPLETED","sponsor":"Innovaderm Research Inc.","startDate":"2009-07","conditions":"Actinic Keratosis","enrollment":20},{"nctId":"NCT00369018","phase":"PHASE1, PHASE2","title":"A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.","status":"COMPLETED","sponsor":"Photocure","startDate":"2006-08","conditions":"Cervical Dysplasia","enrollment":96},{"nctId":"NCT00833183","phase":"PHASE2","title":"Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne","status":"COMPLETED","sponsor":"Photocure","startDate":"2007-07","conditions":"Acne","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":24,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"MAL application","genericName":"MAL application","companyName":"Dong-A University","companyId":"dong-a-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MAL application works by modulating the activity of the MAL protein. Used for Various conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}